期刊文献+

HPLC法测定甲磺酸伊马替尼片的含量 被引量:5

Determination of Imatinib Mesylate Tablets by HPLC
下载PDF
导出
摘要 目的建立高效液相色谱法测定甲磺酸伊马替尼片含量的方法。方法色谱柱为Kromasil C18(4.6 mm×250mm,5μm),以含0.04%辛烷磺酸钠的20 mmol.L-1磷酸二氢钠溶液(磷酸调至pH 2.5)-甲醇(40:60)为流动相,流速为1.0 mL.min-1,检测波长为268 nm,柱温为30℃。结果甲磺酸伊马替尼在25.055~501.1μg.mL-1浓度范围内线性关系良好,r=0.999 9;RSD均小于2%;加样回收率在99.54%~101.23%之间。结论该方法准确、简便、快速,可用于甲磺酸伊马替尼片的含量测定。 Objective To establish an HPLC method for the determination of Imatinib Mesylate Tablets. Methods Kromsil C is column( 4.6 mm × 250 ram,5 μm)was adopted with 20 mmol· L^-1 sodium dihydrogen phosphate containing 0.04% octane sulfonic acid sodium salt( adjusted pH to 2.5 with H3PO4) -methanol(40: 60)as the mobile phase at the flow rate of 1.0 mL · min^-1. The detection wavelength was 268 nm. The column temperature was 30 ℃. Results The imatinib mesylate showed a good linear relationship within the range of 25. 055 - 501.1μg · mL^- 1 ,r = 0. 999 9. All the RSD were less than 2%. The average recoveries were 99.54% - 101.23%. Conclusion This method was accurate,simple and rapid,and it can be used for the determination of Imatinib Mesylate Tablets.
出处 《齐鲁药事》 2012年第11期646-647,共2页 qilu pharmaceutical affairs
关键词 甲磺酸伊马替尼片 含量测定 高效液相色谱法 hnatinib Mesylate Tablets Determination HPLC
  • 相关文献

参考文献1

二级参考文献1

共引文献2

同被引文献43

  • 1宋耕,轩菡,王年飞,王小磊,许苗苗,陈振东.甲磺酸伊马替尼的临床应用研究[J].中华临床医师杂志(电子版),2011,5(24):7348-7350. 被引量:7
  • 2郑斌,危晴岚,刘茂柏.甲磺酸伊马替尼临床研究概况[J].海峡药学,2006,18(6):78-80. 被引量:12
  • 3HUANG Yan(黄艳).Disease treatment targets-tyrosine kinase(疾病治疗的靶点-络氨酸激酶)[J].中国处方药, 2006, 10(43):33.
  • 4Ivanovic D, Medenica M, Jancic B, et al.Reversed-phase liquid chromatography analysis of imatinibmesylate and impurity product in Glivec capsules[J].J Chromatogr B Analyt Technol Biomed Life Sci, 2004, 800(1-2):253.
  • 5Roth O, Spreux-Varoquaux O, Bouchet S, et al.Imatinib assay by HPLC with photodiode-array UV detection in plasma from patients with chronic myeloid leukemia:comparison with LC-MS/ MS[J].Clin Chim Acta, 2010, 411(3-4):140.
  • 6Teoh M, Narayanan P, Moo KS.HPLC determination of imatinib in plasma and tissues after multiple oral dose administration to mice[J].J Pharm Sci, 2010, 23(1):35.
  • 7Vivekanand VV, Sreenivas Rao D, Vaidyanathan G, et al.A validated LC method for imatinibmesylate[J].J Pharm Biomed Anal, 2003, 33(5):879.
  • 8Szczepek WJ, Kosmacinska B, Bielejewska A, et al.Identication of imatinibmesylate degradation products obtained under stress conditions[J].J Pharm Biomed Anal, 2007, 43(5):1682.
  • 9Nageswari A, Reddy KV, Mukkanti K.Stability-indicating UPLC method for determination of imatinibmesylate and their degradation products in active pharmaceutical ingredient and Pharmaceutical dosage forms[J].J Pharm Biomed Anal, 2012, 66:109.
  • 10ZHANG Zhe-feng(张哲峰).Several issues of the relative correlation factors (RCF) for HPLC(HPLC法校正因子研究中的几个问题).Center for drug evaluation, SFDA(国家食品药品监督管理局药品审评中心电子刊物)[EB/OL].2011-12-07.http://www.cde.org.cn/dzkw.do?method=largePage&id=312552.

引证文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部